Densitas intelliMammo Surpasses 2 Million Mammogram Milestone

Early breast cancer detection plays a crucial role in improving patient outcomes. Densitas Inc., a global leader in breast A.I. solutions, has successfully analyzed over 2 million mammograms with densitas intelliMammo.

Densitas is committed to supporting radiologists’ workflows, elevating mammography quality, and enhancing diagnostic confidence with cutting-edge A.I. solutions for breast cancer screening and mammography quality that support early breast cancer detection and treatment.

Elevating Patient Care with On-demand Image Quality, Breast Density, and Breast Cancer Risk Assessments for Entire Populations

With an expanding global presence, Densitas has formed strategic partnerships with leading vendors of diagnostic imaging enterprise solutions, encompassing PACS, RIS, breast imaging reporting systems, strengthening its commitment to revolutionizing mammography quality and transforming patient and population health management.

Densitas has equipped radiologists and radiological technologists across the US, Canada and Europe to efficiently navigate through millions of mammograms, with intelliMammo A.I. solutions providing standardized breast density and mammography positioning quality assessments to enhance radiologists’ diagnostic confidence and act as a second set of eyes to technologists at point-of-care for better image quality.

Enhancing Patient Outcomes and Mammography Workflows

Mo Abdolell, CEO of Densitas, highlights the importance of achieving this milestone, stating, “This achievement resonates deeply with us as a company committed to improving mammography quality. With intelliMammo, we are pioneering evidence-based decision-making and setting new standards for continuous quality improvement in breast cancer screening, empowering providers with the tools they need to elevate patient care while ensuring seamless business continuity.”

Mo Abdolell adds, “With our AI-powered solutions, we’re not just analyzing mammograms; we’re revolutionizing how breast health is managed and working to ensure that early detection becomes a reality for more women. This achievement fuels our drive to push boundaries, setting new benchmarks in breast cancer screening and transforming the landscape of clinical care.”

“Amidst the ongoing workforce crisis, intelliMammo offers an innovative solution to support our current workforce and optimize mammography operations,” said President of University Radiology Group (URG) Roger Yang, MD, FACR. “By automating image quality and breast density assessments, technologists can dedicate more time to performing mammograms and radiologists can focus better on interpreting them, resulting in overall increased efficiency and excellent patient care.”

Empowering Clinical Care Teams

Dr. Jean Seely, Head of Breast Imaging at Ottawa Hospital and Co-Chair of the Canadian Association of Radiologists’ Breast Imaging, explains, “We’re only as good as the images that we’re provided. So if we have images that are poor quality, we don’t know if we have missed any cancer on mammograms. So it’s critical that we have good quality images. I cannot stress that enough. And that’s why intelliMammo is so useful for us as radiologists.”

Dr.Georgia Spear, Chief Breast Imaging at NorthShore University HealthSystem, emphasizes the pivotal role of the software, stating, “Densitas intelliMammo provides the tools to deliver personalized measures of breast density, breast cancer risk, and clinical image quality that can be used to develop unbiased, tailored screening protocols for every woman every time she has a mammogram.”

Densitas solutions present clinical care teams with essential on-demand actionable information and digitized workflows to improve mammography quality, organizational and workflow efficiencies, and evidence-based decision making, to ensure optimal patient care amidst a national crisis of staff burnout and shortages.

Let’s Stay Connected, Subscribe for Updates

Join our email list to stay up to date on the latest advancements in breast health technology.